Publications by authors named "John Stoutenburg"

Claim this Profile
C
Characterization of CD4+CD25+ regulatory T cells in patients treated with high-dose interleukin-2 for metastatic melanoma or renal cell carcinoma.
Giovanni C Cesana, Gail DeRaffele, Seth Cohen, Dorota Moroziewicz, Josephine Mitcham, John Stoutenburg

J Clin Oncol· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial clinical response predicts outcome and is associated with dose schedule in metastatic melanoma and renal cell carcinoma patients treated with high-dose interleukin 2.
Kathryn Spanknebel, Kenneth Y Cheung, John Stoutenburg, Karl Hurst-Wicker, Charles Hesdorffer

Ann Surg Oncol· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant therapy for malignant melanoma.
John P Stoutenburg, Beth Schrope, Howard L Kaufman

Expert Rev Anticancer Ther· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiemetic studies on the NK1 receptor antagonist aprepitant.
John P Stoutenburg, Harry Raftopoulos

J Natl Compr Canc Netw· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis